ETFsXtrackers MSCI World Consumer Staples UCITS ETF 1C
Xtrackers
Xtrackers MSCI World Consumer Staples UCITS ETF 1C
XDWS LSEAccumulatingIreland
Last close · EUR
54.06EUR
-0.27% · -€0.14
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
XDWSBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +24.1%
- Sharpe 3Y
- 0.60
- Volatility 1Y
- 15.2%annualised
- Holdings
- 89Fund holdings
Performance
Compare
- XDWS+24.1%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XDWS | +14.8% | +12.4% | +15.3% | +23.1% | +24.1% | +35.3% | +39.3% |
| MSCI World | -2.8% | -0.6% | +7.8% | +14.3% | +14.1% | +65.6% | +64.8% |
| Gap to MSCI World | +17.6% | +13.0% | +7.5% | +8.8% | +10.0% | -30.3% | -25.6% |
Risk and return
Sharpe ratio · 3Y
0.60
Below MSCI World · 1.24- Return p.a.
- +9.7%
- Volatility
- 12.0%
- Max loss
- -12.2%Sept 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XDWS
0.60
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 59.7%
- Holdings
- 89
- As of
- 1WALMARTUS931142103911.31%
- 2COSTCO WHOLESALE CORPUS22160K10519.28%
- 3PROCTER & GAMBLEUS74271810917.79%
- 4COCA-COLAUS19121610077.42%
- 5PHILIP MORRIS INTERNATIONALUS71817210906.59%
- 6NESTLE SACH00388633505.43%
- 7PEPSICOUS71344810813.89%
- 8UNILEVER PLCGB00BVZK7T902.89%
- 9ALTRIA GROUP INCUS02209S10332.61%
- 10BRITISH AMERICAN TOBACCOGB00028758042.51%
Countries
Classified 99.8%
United States65.9%
GB
CH
JP
FR
CA
BE
NL
- Largest
- 65.9%United States
- Top 3
- 81.9%
- Effective number
- 2.21 / HHI
Market cap
Weight vs holdings
59.7%of the fund sits in the top 10 holdings
59.7%32.6%
WeightHoldings
104039
- Holdings 1-10
- Holdings 11-50
- Holdings 51-89
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
